Zoryve
Active Ingredient(s): RoflumilastFDA Approved: * July 29, 2022
Pharm Company: * ARCUTIS
Category: Lungs (Pulmonary)
Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).[6][7][8][9] In June 2010, it was approved in the European Union for severe COPD assoc... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.